MarketsandMarkets is providing a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2022 Confex on the 3rd & 4th February 2022 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Microbiome and Genome engineering areas.
With growing pressures of increasing success rates for FDA approved biomarkers as well as companion diagnostics tests has seen an outgrowth in drug discovery companies to invest in novel strategies for biomarker discovery. The industry of genome editing has witnessed some great breakthroughs during a year in the areas like genome writing, base editing and specific progression in the field of therapeutics through the Car-T cells and immunotherapy. With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.
The three conferences which are going to be a part of Biogene Confex 2022 are, 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference, 4th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference and 2nd Annual MarketsandMarkets Advanced Genetic Sequencing Conference
From Pharmaceutical and Bio-pharmaceutical companies:
Chief Scientific Officers/ Chief Executive Officer’s/Senior Scientists/ Principal Scientists/CMO/ CTO/ Director/ VP/ Head/ Manager/ Lead Architects/ Lead Engineers/ Group leaders/ Clinicians/ Practitioners (Physicians)/ Professors/ Project Leaders Heads.
From Universities and Research institutes:
Professors/ Assistant Professors/ Researchers/ Scientists/ Principal Scientists